Cargando…

The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study

BACKGROUND: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. AIMS: We aim to quantify and bring together a variety of international perspectives from ophthalmologists...

Descripción completa

Detalles Bibliográficos
Autores principales: Waisberg, Ethan, Ong, Joshua, Zaman, Nasif, Kamran, Sharif Amit, Tavakkoli, Alireza, Lee, Andrew G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918813/
https://www.ncbi.nlm.nih.gov/pubmed/36773204
http://dx.doi.org/10.1007/s11845-023-03306-9
_version_ 1785145834813259776
author Waisberg, Ethan
Ong, Joshua
Zaman, Nasif
Kamran, Sharif Amit
Tavakkoli, Alireza
Lee, Andrew G.
author_facet Waisberg, Ethan
Ong, Joshua
Zaman, Nasif
Kamran, Sharif Amit
Tavakkoli, Alireza
Lee, Andrew G.
author_sort Waisberg, Ethan
collection PubMed
description BACKGROUND: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. AIMS: We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease. METHODS: An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program. RESULTS: Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance. CONCLUSIONS: Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19.
format Online
Article
Text
id pubmed-9918813
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99188132023-12-03 The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study Waisberg, Ethan Ong, Joshua Zaman, Nasif Kamran, Sharif Amit Tavakkoli, Alireza Lee, Andrew G. Ir J Med Sci Brief Report BACKGROUND: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. AIMS: We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease. METHODS: An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program. RESULTS: Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance. CONCLUSIONS: Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19. Springer International Publishing 2023-02-11 2023 /pmc/articles/PMC9918813/ /pubmed/36773204 http://dx.doi.org/10.1007/s11845-023-03306-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Report
Waisberg, Ethan
Ong, Joshua
Zaman, Nasif
Kamran, Sharif Amit
Tavakkoli, Alireza
Lee, Andrew G.
The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
title The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
title_full The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
title_fullStr The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
title_full_unstemmed The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
title_short The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
title_sort impact of covid-19 on managing ophthalmic diseases: an international, descriptive study
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918813/
https://www.ncbi.nlm.nih.gov/pubmed/36773204
http://dx.doi.org/10.1007/s11845-023-03306-9
work_keys_str_mv AT waisbergethan theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT ongjoshua theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT zamannasif theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT kamransharifamit theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT tavakkolialireza theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT leeandrewg theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT waisbergethan impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT ongjoshua impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT zamannasif impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT kamransharifamit impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT tavakkolialireza impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy
AT leeandrewg impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy